In tumor cells, including TNBC cells, an upregulation of stress-induced ligands has frequently been reported; NKG2D can naturally recognize these ligands [95] so it has been considered as a potential target for immunotherapy in several studies. The gene discussed is KLRK1; the disease is neoplasm.